Enantia at DCAT Week 2026

Enantia will be in New York next week during DCAT Week, one of the key global gatherings for the pharmaceutical manufacturing and outsourcing industry.
At Enantia, we support pharmaceutical and biotech partners with strong expertise in small-molecule chemical R&D and development, including process chemistry and manufacturing of small-molecule APIs. Our team works closely with partners to design efficient synthetic routes and robust processes suitable for scale-up.
We also have strong capabilities in the development of highly potent small molecules (HPAPIs), supporting projects that require specialized handling and expertise in highly potent compounds.

In addition to small-molecule chemical development, we provide solid-state screening services, including polymorph and cocrystal identification, helping improve small-molecule API properties such as solubility, stability, and manufacturability while also creating opportunities to strengthen intellectual property protection.

If you will also be in New York during DCAT Week and would like to explore how Enantia could support your small-molecule drug development programs, we would be pleased to connect.